CJC-1295 references separate the tested substances and subjects

The numbered papers tell you which findings apply

The research compound CJC-1295 has only a few human studies. The numbered papers help you examine the evidence for a claim.

Teichman 2006 ^[1] and Ionescu/Frohman 2006 ^[3] measured hormone responses in healthy adults. Jette 2005 ^[2] examined the albumin bond; Alba 2006 ^[7] examined growth in mice lacking a growth-related hormone.

The papers also cover sleep, other blood proteins, related medicines, and cancer links, but you need each finding paired with the tested substance and the people or animals who received the substance. You can open the numbered links to read the original findings.

Scientists' and suppliers' reference lists disagree about the study compound's exact chemical make-up. Those lists describe substances, rather than testing what's inside a seller's bottle, so a result belongs to the tested compound and doesn't verify every bottle bearing its name.

The named human CJC-1295 studies chiefly measured blood

Teichman 2006 found larger hormone rises after larger amounts in healthy adults ^[1]. Growth hormone and IGF-1, the liver's growth protein, stayed raised for days.

Ionescu and Frohman 2006 found extra hormone between the usual bursts ^[3]. Sackmann-Sala 2009 found greater rises in other blood proteins when IGF-1 rose more ^[5].

These early CJC-1295 tests don't establish lasting benefits or safety for you. Development stopped at Phase 2, an early stage of examining treatment benefits and harm in patients.

The patients had HIV infection and excess fat deep inside the belly; HIV weakens the body's defence against germs. You still lack large studies following healthy adults for lasting benefits and harm.

Animal results and related medicines answer different questions

Jette 2005 compared CJC-1295 with and without the albumin bond in rats ^[2]. The total from hormone readings was 4-fold, or four times the total without the bond.

Researchers estimated this total by adding repeated blood readings. Higher readings count more; high readings that continue count more again.

Alba 2006 restored normal growth with daily shots in mice missing a growth-related hormone ^[7]. Steiger 1992 increased deep sleep in men given the body's natural release hormone ^[6].

Raun 1998 examined ipamorelin in animals and rat cells in a dish ^[4]. Other ipamorelin work examined hormone responses and bone growth ^[8][9].

Tesamorelin has separate human trials ^[12][13]. Renehan 2004 examined cancer links with the liver's growth protein ^[14]; further papers cover related substances and sleep's role in hormone release ^[10][11].